Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors
- 16 May 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (10) , 4279-4292
Abstract
The dCTP pyrophosphatase 1 (dCTPase) is a nucleotide pool “housekeeping” enzyme responsible for the catabolism of canonical and noncanonical nucleoside triphosphates (dNTPs) and has been associated with cancer progression and cancer cell stemness. We have identified a series of piperazin-1-ylpyridazines as a new class of potent dCTPase inhibitors. Lead compounds increase dCTPase thermal and protease stability, display outstanding selectivity over related enzymes and synergize with a cytidine analogue against leukemic cells. This new class of dCTPase inhibitors lays the first stone toward the development of drug-like probes for the dCTPase enzyme.Keywords
Funding Information
- Vetenskapsr?det
- G?ran Gustafssons Stiftelse f?r Naturvetenskaplig och Medicinsk Forskning
- Knut och Alice Wallenbergs Stiftelse
- Torsten S?derbergs Stiftelse
- Cancerfonden
- H2020 European Research Council
- Swedish Children?s Cancer Foundation
- Felix Mindus bidrag till leukemiforskningen
- Swedish Pain Relief Foundation
This publication has 25 references indexed in Scilit:
- dCTP pyrophosphohydrase exhibits nucleic accumulation in multiple carcinomasEuropean Journal of Histochemistry, 2013
- Rapid Measurement of Intracellular Unbound Drug ConcentrationsMolecular Pharmaceutics, 2013
- Discovery of Piperazin-1-ylpyridazine-Based Potent and Selective Stearoyl-CoA Desaturase-1 Inhibitors for the Treatment of Obesity and Metabolic SyndromeJournal of Medicinal Chemistry, 2013
- Triptolide Directly Inhibits dCTP PyrophosphataseChemBioChem, 2011
- Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS)ACS Medicinal Chemistry Letters, 2010
- Target identification using drug affinity responsive target stability (DARTS)Proceedings of the National Academy of Sciences, 2009
- Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 InhibitorsJournal of Medicinal Chemistry, 2007
- Ligand efficiency indices as guideposts for drug discoveryDrug Discovery Today, 2005
- Evaluation of fluorescence-based thermal shift assays for hit identification in drug discoveryAnalytical Biochemistry, 2004
- A new micromethod for the colorimetric determination of inorganic phosphateClinica Chimica Acta, 1966